Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel antiplatelet agent discovered and characterized at Yamanouchi

July 2, 2002

Purification process for amediplase successfully developed through collaboration

July 1, 2002

AstraZeneca claims P2T antagonists for antiplatelet therapy

June 25, 2002

3-Dimensional presents new trypsin-like protease inhibitors in recent patent

June 20, 2002

Carrier-mediated active transport is responsible for hepatic uptake of Z-335

June 12, 2002

Novel factor Xa inhibitors claimed by Merck KGaA

June 11, 2002

Pharmion acquires Refludan rights outside North America

June 6, 2002

Daiichi patents factor Xa-inhibitory amidines

June 5, 2002

Aventis initiates Lovenox trial in patients with acute STEMI

June 4, 2002

Ajinomoto describes factor Xa-inhibitory benzodiazepines

June 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...